中国卫生集团(00673.HK)收购分子诊断技术公司交易失效

阿斯达克财经
02 Jul

中国卫生集团(00673.HK) 公布,公司连同其附属公司就日期为2024年7月7日有关建议收购谱天福信(天津)分子诊断技术有限公司100%股权之公布,指由于若干先决条件于经延长最后截止日期前未获达成(或豁免),且订约各方概无就进一步延长经延长最后截止日期达成协议,故协议及订约各方根据协议之所有权利及义务应予终止。

董事会认为,终止协议及主要交易失效将不会对集团现有业务、营运或财务状况造成任何重大不利影响。(hc/da)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10